Journal profile · RHEUMATOLOGY

Journal of Scleroderma and Related Disorders

ISSN 2397-1983 · eISSN 2397-1991 · SAGE

Journal of Scleroderma and Related Disorders: CAS Zone 4 · Medicine (2025 upgraded edition); hybrid open access; APC about USD 4,150; median 61 days to acceptance (66 articles, last 24 months); 53 articles in 2025; indexed in ESCI and Scopus.

Impact factor—No published value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time61 daysMedian, submission to acceptance · 66 articles, last 24 months · PubMed
APCUSD 4,150Hybrid journal: charged only for open-access articles
Acceptance—No reports yet
Articles per year532025 · OpenAlex count

Scope

Aims, scope and focus

Journal of Scleroderma and Related Disorders is published by SAGE and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Systemic Sclerosis and Related Diseases, Inflammatory Myopathies and Dermatomyositis and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, together about 58.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

From 1st January 2026, the journal will be published by BMJ. Please direct your queries to Christiane Notarmarco (cnotarmarco@bmj.com) or visit the...

From the journal's Aims & Scope

Research area (LetPub): RHEUMATOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Systemic Sclerosis and Related DiseasesMedicine38.1%
  2. Inflammatory Myopathies and DermatomyositisMedicine10.1%
  3. Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine9.9%
  4. Dermatologic Treatments and ResearchMedicine7.4%
  5. Multiple Sclerosis Research StudiesMedicine5%
  6. Skin Diseases and DiabetesMedicine4.9%
  7. Diagnosis and Treatment of Venous DiseasesMedicine3.7%
  8. Pulmonary Hypertension Research and TreatmentsMedicine3.5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRheumatologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRheumatologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
2.6LetPub ·
SJR 2026-06
0.63LetPub ·
SNIP 2026-06
0.77LetPub ·
h-index
34OpenAlex ·
i10-index
128OpenAlex ·
2-year mean citedness
1.79OpenAlex ·
Self-citation rate
13.3%LetPub ·
Share of gold OA articles
24.59%LetPub ·

Volume

Articles per year
50LetPub ·

Articles by year OpenAlex count · 447 in total · the current year is incomplete

YearArticlesOpen accessCitations
202622225
20255353119
2024484796
20233030171
20223838226
20213535391

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

61 daysMedian, submission to acceptance · P25–P75 35 days – 87 days

Acceptance to online
median 34 days (67 articles)
Submission to online
median 95 days
Sample
66 articles with submission and acceptance dates (90 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 4,150 / GBP 3,043——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
SAGE
ISSN
2397-1983
Electronic ISSN
2397-1991
Official links

FAQ

Frequently asked questions about Journal of Scleroderma and Related Disorders

What CAS zone is Journal of Scleroderma and Related Disorders in?

In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Scleroderma and Related Disorders is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

How long does peer review take at Journal of Scleroderma and Related Disorders?

Based on the dates recorded on 66 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 61 days (interquartile range 35–87 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Journal of Scleroderma and Related Disorders?

According to LetPub and DOAJ records, Journal of Scleroderma and Related Disorders is indexed in ESCI and Scopus.

Is Journal of Scleroderma and Related Disorders open access, and what is the APC?

Journal of Scleroderma and Related Disorders is a hybrid journal. For open-access publication: APC about USD 4,150.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .